These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2497229)

  • 21. [Clinical characteristics of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) in adult].
    Horata-Takahashi E; Kamata K; Takeuchi Y; Kikawada R; Okubo M
    Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):727-39. PubMed ID: 8084074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient.
    Gordon LI; Kwaan HC
    Semin Thromb Hemost; 1999; 25(2):217-21. PubMed ID: 10357089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes.
    Kojouri K; Vesely SK; George JN
    Ann Intern Med; 2001 Dec; 135(12):1047-51. PubMed ID: 11747383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mitomycin C associated hemolytic uremic syndrome--a case report and review of the Japanese cases].
    Shirakawa K; Morita S; Tojo M; Tsuda M; Uchida R; Mimoto H; Hatamori N; Okabayashi Y; Saeki S; Oimomi M
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2057-61. PubMed ID: 8215482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Bittencourt CE; Ha JP; Maitta RW
    PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials.
    Ntukidem N; Arce-Lara C; Otterson GA; Kraut E; Cataland S; Bekaii-Saab T
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):319-24. PubMed ID: 19506871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Vesely SK; Li X; McMinn JR; Terrell DR; George JN
    Transfusion; 2004 Aug; 44(8):1149-58. PubMed ID: 15265118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases.
    Giroux L; Bettez P; Giroux L
    Am J Kidney Dis; 1985 Jul; 6(1):28-39. PubMed ID: 3927715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemolytic-uremic syndrome and acute renal failure in metastatic adenocarcinoma treated with mitomycin: case report and literature review.
    D'Elia JA; Aslani M; Schermer S; Cloud L; Bothe A; Dzik W
    Ren Fail; 1987; 10(2):107-13. PubMed ID: 3120247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases.
    Dervenoulas J; Tsirigotis P; Bollas G; Pappa V; Xiros N; Economopoulos T; Pappa M; Mellou S; Kostourou A; Papageorgiou E; Raptis SA
    Ann Hematol; 2000 Feb; 79(2):66-72. PubMed ID: 10741917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Microangiopathic hemolytic anemia (MAHA) observed after administration of mitomycin C (MMC)].
    Yasunaga C; Komota T; Mimura K; Kinjyo M; Sueishi K; Hirose T
    Gan No Rinsho; 1987 Jun; 33(7):854-60. PubMed ID: 3112442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Three cases of drug-induced hemolytic uremic syndrome].
    Tohda S; Shiigai T; Jibiki M; Aoi T; Ueda Y; Kawasaki T; Kurokawa H; Nara N
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):361-4. PubMed ID: 8712831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciprofloxacin-associated hemolytic-uremic syndrome.
    Allan DS; Thompson CM; Barr RM; Clark WF; Chin-Yee IH
    Ann Pharmacother; 2002 Jun; 36(6):1000-2. PubMed ID: 12022900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syndromes of Thrombotic Microangiopathy.
    Shatzel JJ; Taylor JA
    Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TTP/HUS and prognosis: the syndrome and the disease(s).
    Forzley BR; Clark WF
    Kidney Int Suppl; 2009 Feb; (112):S59-61. PubMed ID: 19180139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Laboratory Consequences of Platelet Transfusion in Shiga Toxin-Mediated Hemolytic Uremic Syndrome.
    Beneke J; Sartison A; Kielstein JT; Haller H; Nitschke M; Kunzendorf U; Loos S; Kemper MJ; Stahl RA; Menne J;
    Transfus Med Rev; 2017 Jan; 31(1):51-55. PubMed ID: 27468945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome (TTP/HUS). Description of a series of 35 patients].
    Martínez Francés A; Pereira A; Ordinas A
    Med Clin (Barc); 1997 Jun; 109(2):49-52. PubMed ID: 9280801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; Gutiérrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 39. A patient with Crohn's disease who presented with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome.
    Unverdi S; Ceri M; Öztürk MA; Akbal E; Ensari A; Yılmaz R; Kocak E; Inal S; Koklu S; Duranay M
    Ren Fail; 2011; 33(2):244-5. PubMed ID: 21332348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitomycin C-induced renal toxicity, a dose-dependent side effect?
    Verwey J; de Vries J; Pinedo HM
    Eur J Cancer Clin Oncol; 1987 Feb; 23(2):195-9. PubMed ID: 3127216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.